Roivant Sciences (ROIV) Cash from Investing Activities (2020 - 2025)

Roivant Sciences has reported Cash from Investing Activities for 6 years, with the latest figure at -$855.8 million in Q4 2025.

• For the quarter ending Q4 2025, Cash from Investing Activities rose 69.87% year-over-year to -$855.8 million; the trailing twelve-month figure through Dec 2025 stood at -$4.7 billion (down 396.79% YoY), and the FY2026 full-year result was -$682.3 million, up 61.37% from the prior year.
• Cash from Investing Activities for Q4 2025 stood at -$855.8 million, down from $120.4 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $5.2 billion in Q4 2023, with the low at -$3.3 billion in Q3 2024.
• Historically, Cash from Investing Activities has averaged -$165.6 million across 5 years, with a median of -$7.5 million in 2022.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 3392.76% — and 2025, when it tumbled 112409.43%.
• Roivant Sciences' Cash from Investing Activities stood at $309.0 million in 2021, then sank by 151.08% to -$157.8 million in 2022, then soared by 3392.76% to $5.2 billion in 2023, then plunged by 154.66% to -$2.8 billion in 2024, then soared by 69.87% to -$855.8 million in 2025.
• The last three Cash from Investing Activities figures came in at -$855.8 million (Q4 2025), $120.4 million (Q3 2025), and -$1.1 billion (Q2 2025), per Business Quant data.